Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy (Q24201954)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy	scientific article

Statements

scholarly article

0 references

0 references

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy (English)

0 references

chronic inflammatory demyelinating polyradiculoneuropathy

0 references

0 references

Pieter A van Doorn

2

object named as

Pieter A van Doorn

0 references

author name string

Mohamed Mahdi-Rogers

1

0 references

Richard AC Hughes

3

0 references

publication date

14 June 2013

0 references

Cochrane Database of Systematic Reviews

0 references

Treatment for IgG and IgA paraproteinaemic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Mycophenolate mofetil in dysimmune neuropathies: a preliminary study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

129th ENMC International Workshop: Clinical Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy, 27th October 2004, Schiphol airport, The Netherlands.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

The AMC Linear Disability Score project in a population requiring residential care: psychometric properties

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

EBV-associated lymphoma and chronic inflammatory demyelinating polyneuropathy in an adult without overt immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Distal acquired demyelinating symmetric neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Azathioprine toxicity in neuromuscular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Sustained remission of CIDP associated with Evans syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of inflammatory and paraproteinemic neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of dys-immune neuropathies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

"Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Subacute inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Nonmyeloablative autologous hematopoietic stem celltransplantation for refractory CIDP.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Clinical spectrum of chronic acquired demyelinating polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic acquired demyelinating polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Mycophenolate in treatment-resistant inflammatory neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Interferon beta-1a as an investigational treatment for CIDP.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of Guillain-Barré syndrome and CIDP.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Systematic reviews of treatment for inflammatory demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab therapy in monoclonal IgM-related neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Subacute Idiopathic Demyelinating Polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic relapsing inflammatory demyelinating polyneuropathy by cyclosporin A and plasma exchange. A case report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic relapsing polyneuritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

[Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic polyneuropathies in Vest-Agder, Norway

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Focal upper limb demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Pe

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab-responsive CIDP

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

CIDP cured by allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prevalence of CIDP and the association of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of monoclonal protein in peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifocal demyelinating neuropathy with persistent conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-beta1a in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide without stem-cell rescue for refractory CIDP

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Exacerbation of chronic inflammatory demyelinating polyradiculoneuropathy during interferonbeta-1b therapy in a patient with childhood-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD003280.PUB4

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24201954&oldid=1475199760"